Jonathan Roiser

Jonathan Roiser


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2013 in Psychological Medicine
Verified
Journal Article
Closed access
PRP. L. Rock
P. L. Rock
JRJonathan Roiser
Jonathan Roiser
WRW. J. Riedel
W. J. Riedel
ABA. D. Blackwell
A. D. Blackwell
Background: This review aimed to address the question of whether cognitive impairment should be considered a core feature of depression that may be a valuable target for treatment.Method: We conducted a systematic review and meta-analysis of cognitive function, assessed with a single neuropsychological test battery, the Cambridge Neuropsychological Test Automated Battery (CANTAB), in patients with depression during symptomatic and remitted states. Inclusion of studies comparing patients remitted from depression and controls enabled us to investigate whether cognitive impairment persists beyond episodes of low mood in depression.Results: Our meta-analysis revealed significant moderate cognitive deficits in executive function, memory and attention in patients with depression relative to controls (Cohen'sdeffect sizes ranging from −0.34 to −0.65). Significant moderate deficits in executive function and attention (Cohen'sdranging from −0.52 to −0.61) and non-significant small/moderate deficits in memory (Cohen'sdranging from −0.22 to −0.54) were found to persist in patients whose depressive symptoms had remitted, indicating that cognitive impairment occurs separately from episodes of low mood in depression.Conclusions: Both low mood and cognitive impairment are associated with poor psychosocial functioning. Therefore, we argue that remediation of cognitive impairment and alleviation of depressive symptoms each play an important role in improving outcome for patients with depression. In conclusion, this systematic review and meta-analysis demonstrates that cognitive impairment represents a core feature of depression that cannot be considered an epiphenomenon that is entirely secondary to symptoms of low mood and that may be a valuable target for future interventions.

26 June 2018 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
MHMasud Husain
Masud Husain
JRJonathan Roiser
Jonathan Roiser

1 March 2018 in The Lancet Psychiatry
Verified
Journal Article
Closed access
EHEmily A Holmes
Emily A Holmes
Ata GhaderiAta Ghaderi
Ata Ghaderi
CHCatherine J Harmer
Catherine J Harmer
PRPaul G Ramchandani
Paul G Ramchandani
PCPim Cuijpers
Pim Cuijpers
MCMichelle G Craske
Michelle G Craske

1 July 2010 in Biological Psychiatry
Verified
Journal Article
Closed access
NENeir Eshel
Neir Eshel
JRJonathan Roiser
Jonathan Roiser

5 October 2011 in Neuropsychopharmacology
Verified
Journal Article
Closed access
JRJonathan Roiser
Jonathan Roiser
RERebecca Elliott
Rebecca Elliott
BSBarbara J Sahakian
Barbara J Sahakian

1 July 2012 in Neuroscience
Verified
Journal Article
Open access
JDJ.W. Dalley
J.W. Dalley
JRJonathan Roiser
Jonathan Roiser
Impulsive people have a strong urge to act without thinking. It is sometimes regarded as a positive trait but rash impulsiveness is also widely present in clinical disorders such as attention deficit hyperactivity disorder (ADHD), drug dependence, mania, and antisocial behaviour. Contemporary research has begun to make major inroads into unravelling the brain mechanisms underlying impulsive behaviour with a prominent focus on the limbic cortico-striatal systems. With this progress has come the understanding that impulsivity is a multi-faceted behavioural trait involving neurally and psychologically diverse elements. We discuss the significance of this heterogeneity for clinical disorders expressing impulsive behaviour and the pivotal contribution made by the brain dopamine and serotonin systems in the aetiology and treatment of behavioural syndromes expressing impulsive symptoms.